{"id":13883,"date":"2022-02-27T22:26:57","date_gmt":"2022-02-27T22:26:57","guid":{"rendered":"https:\/\/www.fetaldna.it\/publications\/"},"modified":"2022-02-28T22:59:23","modified_gmt":"2022-02-28T22:59:23","slug":"publications","status":"publish","type":"page","link":"https:\/\/www.fetaldna.it\/en\/publications\/","title":{"rendered":"Articles"},"content":{"rendered":"

[vc_row full_width=”stretch_row” softing_row_overlay_type=”custom” softing_bg_attachment=”fixed” softing_lg_bgpos=”center” softing_row_overlayclr=”rgba(242,72,62,0.4)” css=”.vc_custom_1640178087195{padding-top: 100px !important;padding-bottom: 100px !important;background-image: url(https:\/\/www.fetaldna.it\/wp-content\/uploads\/2021\/12\/Sfondo_Altamedica_grigio-1.png?id=13217) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column css=”.vc_custom_1640178140620{padding-top: 100px !important;padding-bottom: 54px !important;}”][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_custom_heading text=”ARTICLES LIST” font_container=”tag:h1|text_align:left” use_theme_fonts=”yes”][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_column_text]Dello Russo C., Cesta A., Longo S., Barone M.A., Cima A., Mesoraca A., Sparacino D., Viola A., Giorlandino C.[\/vc_column_text][vc_custom_heading text=”Validation of Extensive Next-Generation Sequencing Method for Monogenic Disorder Analysis on Cell-Free Fetal DNA: Noninvasive Prenatal Diagnosis” font_container=”tag:h3|text_align:left” use_theme_fonts=”yes” link=”url:https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F31028936%2F|target:_blank|”][vc_column_text]J Mol Diagn, 2019 Jul 21<\/em>[\/vc_column_text][vc_message message_box_color=”grey” icon_fontawesome=”fas fa-caret-right”]<\/p>\n

ABSTRACT<\/h3>\n

During pregnancy, a percentage of the cell-free DNA circulating in the maternal blood is represented by the cell-free fetal DNA (cffDNA), constituting an accessible source for noninvasive prenatal genetic screening. The coexistence of the maternal DNA, the dominant fraction of cell-free DNA, together with the cffDNA component and the scarcity of the cffDNA itself make applying traditional methods of genetics and molecular biology impossible.<\/p>\n

Next-generation sequencing methods are widely used to study fetal aneuploidies. However, in monogenic disorders, there have been relatively few studies that analyzed single mutations. We present a method for the analysis of an extended group of gene variants associated with recessive and dominant autosomal disorders using next-generation sequencing.<\/p>\n

. The proposed test should allow a complete analysis of common genetic disorders and pathogen-associated variants for diagnostic use. The analysis of cffDNA for single gene disorders may replace invasive prenatal diagnosis methods, associated with the risk of spontaneous abortion and psychological stress for patients. The proposed test should assess reproductive risk for both genetic family disorders and de novo occurrences of the disease. The application of this method to a case of beta-thalassemia is also discussed.[\/vc_message][vc_row_inner][vc_column_inner width=”5\/6″][vc_column_text]https:\/\/pubmed.ncbi.nlm.nih.gov\/31028936\/<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_column_text]Mesoraca A., Margiotti K., Dello Russo C., Cesta A., Cima A., Longo S., Barone M. A., Viola. A, Sparacino D., Giorlandino C.[\/vc_column_text][vc_custom_heading text=”Cell-free DNA screening for aneuploidies in 7113 pregnancies: single Italian centre study” font_container=”tag:h3|text_align:left” use_theme_fonts=”yes” link=”url:https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F32539871%2F|target:_blank|”][vc_column_text]Genet Res (Camb), 2020 Jun 16<\/em>[\/vc_column_text][vc_message message_box_color=”grey” icon_fontawesome=”fas fa-caret-right”]<\/p>\n

ABSTRACT<\/h3>\n

Non-invasive prenatal testing (NIPT) using cell-free foetal DNA has been widely accepted in recent years for detecting common foetal chromosome aneuploidies, such as trisomies 13, 18 and 21, and sex chromosome aneuploidies.<\/p>\n

In this study, the practical clinical performance of our foetal DNA testing was evaluated for analysing all chromosome aberrations among 7113 pregnancies in Italy. In this study, NIPT showed 100% sensitivity and 99.9% specificity for trisomies 13, 18 and 21.[\/vc_message][vc_row_inner][vc_column_inner width=”5\/6″][vc_column_text]https:\/\/pubmed.ncbi.nlm.nih.gov\/32539871\/<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_column_text]Margiotti K., Cesta A., Dello Russo C., Cima A., Barone M.A., Viola A., Sparacino D., Mesoraca A., Giorlandino C.[\/vc_column_text][vc_custom_heading text=”Cell-free DNA screening for sex chromosomal aneuploidies in 9985 pregnancies: Italian single experience” font_container=”tag:h3|text_align:left” use_theme_fonts=”yes” link=”url:https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F32188487%2F|target:_blank|”][vc_column_text]BMC Res Notes, 2020 Mar 18<\/em>[\/vc_column_text][vc_message message_box_color=”grey” icon_fontawesome=”fas fa-caret-right”]<\/p>\n

ABSTRACT<\/h3>\n

In this study, the clinical performance of our fetal DNA testing was investigated by analyzing the sex chromosome ane- uploidy aberrations among 9985 pregnancies. The study was a retrospective analysis of collected NIPT data from the Ion S5 next-generation sequencing (NGS) platform obtained from Altamedica Medical Centre of Rome.<\/p>\n

In conclusion, the present results confirm that NIPT is a potential method for SCA screening[\/vc_message][vc_row_inner][vc_column_inner width=”5\/6″][vc_column_text]https:\/\/pubmed.ncbi.nlm.nih.gov\/32188487\/<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_separator color=”custom” style=”dashed” border_width=”2″ accent_color=”#f2483e”][\/vc_column][\/vc_row][vc_row softing_row_overlay_type=”custom”][vc_column][vc_custom_heading text=”OTHER REFERENCES” font_container=”tag:h1|text_align:left” use_theme_fonts=”yes”][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_column_text]Orhant L., Rondeau S., Vasson A., Anselem O., Goffinet F., Allach El Khattabi L., Leturcq F., Vidaud D., Bienvenu T., Tsatsaris V., Nectoux,[\/vc_column_text][vc_custom_heading text=”Droplet digital PCR, a new approach to analyze fetal DNA from maternal blood: application to the determination of fetal RHD genotype” font_container=”tag:h3|text_align:left” use_theme_fonts=”yes”][vc_column_text]Ann Biol Clin. 2016 Jun 1<\/em>[\/vc_column_text][vc_row_inner][vc_column_inner width=”5\/6″][vc_column_text]https:\/\/pubmed.ncbi.nlm.nih.gov\/27237800\/<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_column_text]Liao G.J., Gronowski A.M., Zhao Z.[\/vc_column_text][vc_custom_heading text=”Non-invasive prenatal testing using cell-free fetal DNA in maternal circulation” font_container=”tag:h3|text_align:left” use_theme_fonts=”yes”][vc_column_text]Clin. Chim. Acta. 2014 Jan 20<\/em>[\/vc_column_text][vc_row_inner][vc_column_inner width=”5\/6″][vc_column_text]https:\/\/pubmed.ncbi.nlm.nih.gov\/24482806\/<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_column_text]El Khattabi L.A., Rouillac-Le Sciellour C., Le Tessier D., Luscan A., Coustier A., Porcher R.[\/vc_column_text][vc_custom_heading text=”Could Digital PCR Be an Alternative as a Non-Invasive Prenatal Test for Trisomy 21: A Proof of Concept Study” font_container=”tag:h3|text_align:left” use_theme_fonts=”yes”][vc_column_text]PLoS One. 2016 May 11<\/em>[\/vc_column_text][vc_row_inner][vc_column_inner width=”5\/6″][vc_column_text]https:\/\/pubmed.ncbi.nlm.nih.gov\/27167625\/<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_column_text]Jeon Y.J., Zhou Y., Li Y., Guo Q., Chen J.[\/vc_column_text][vc_custom_heading text=”The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform” font_container=”tag:h3|text_align:left” use_theme_fonts=”yes”][vc_column_text]PLoS One. 2014 Oct 20<\/em>[\/vc_column_text][vc_row_inner][vc_column_inner width=”5\/6″][vc_column_text]https:\/\/pubmed.ncbi.nlm.nih.gov\/25329639\/<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_column_text]Karakas B., Qubbaj W., Al-Hassan S., Coskun S.[\/vc_column_text][vc_custom_heading text=”Noninvasive Digital Detection of Fetal DNA in Plasma of 4-Week-Pregnant Women following In Vitro Fertilization and Embryo Transfer” font_container=”tag:h3|text_align:left” use_theme_fonts=”yes”][vc_column_text]PLoS One. 2015 May 13<\/em>[\/vc_column_text][vc_row_inner][vc_column_inner width=”5\/6″][vc_column_text]https:\/\/pubmed.ncbi.nlm.nih.gov\/25970589\/<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row full_width=”stretch_row” softing_row_overlay_type=”custom” softing_bg_attachment=”fixed” softing_lg_bgpos=”center” softing_row_overlayclr=”rgba(242,72,62,0.4)” css=”.vc_custom_1640178087195{padding-top: 100px !important;padding-bottom: 100px !important;background-image: url(https:\/\/www.fetaldna.it\/wp-content\/uploads\/2021\/12\/Sfondo_Altamedica_grigio-1.png?id=13217) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column css=”.vc_custom_1640178140620{padding-top: 100px !important;padding-bottom: 54px !important;}”][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_custom_heading text=”ARTICLES LIST” font_container=”tag:h1|text_align:left” use_theme_fonts=”yes”][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_column_text]Dello Russo C., Cesta A., Longo S., Barone M.A., Cima A., Mesoraca A., Sparacino D., Viola A., Giorlandino C.[\/vc_column_text][vc_custom_heading text=”Validation of Extensive Next-Generation Sequencing…<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"custom-page.php","meta":{"footnotes":""},"class_list":["post-13883","page","type-page","status-publish","hentry"," c-blog-1-item nt-post-class"],"yoast_head":"\nArticles - FetalDNA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fetaldna.it\/en\/publications\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Articles - FetalDNA\" \/>\n<meta property=\"og:description\" content=\"[vc_row full_width=”stretch_row” softing_row_overlay_type=”custom” softing_bg_attachment=”fixed” softing_lg_bgpos=”center” softing_row_overlayclr=”rgba(242,72,62,0.4)” css=”.vc_custom_1640178087195{padding-top: 100px !important;padding-bottom: 100px !important;background-image: url(https:\/\/www.fetaldna.it\/wp-content\/uploads\/2021\/12\/Sfondo_Altamedica_grigio-1.png?id=13217) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column css=”.vc_custom_1640178140620{padding-top: 100px !important;padding-bottom: 54px !important;}”][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_custom_heading text=”ARTICLES LIST” font_container=”tag:h1|text_align:left” use_theme_fonts=”yes”][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_column_text]Dello Russo C., Cesta A., Longo S., Barone M.A., Cima A., Mesoraca A., Sparacino D., Viola A., Giorlandino C.[\/vc_column_text][vc_custom_heading text=”Validation of Extensive Next-Generation Sequencing...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fetaldna.it\/en\/publications\/\" \/>\n<meta property=\"og:site_name\" content=\"FetalDNA\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-28T22:59:23+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.fetaldna.it\\\/en\\\/publications\\\/\",\"url\":\"https:\\\/\\\/www.fetaldna.it\\\/en\\\/publications\\\/\",\"name\":\"Articles - FetalDNA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fetaldna.it\\\/#website\"},\"datePublished\":\"2022-02-27T22:26:57+00:00\",\"dateModified\":\"2022-02-28T22:59:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.fetaldna.it\\\/en\\\/publications\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.fetaldna.it\\\/en\\\/publications\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.fetaldna.it\\\/en\\\/publications\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.fetaldna.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Articles\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.fetaldna.it\\\/#website\",\"url\":\"https:\\\/\\\/www.fetaldna.it\\\/\",\"name\":\"FetalDNA | Il test prenatale su DNA fetale\",\"description\":\"Il test prenatale di ultima generazione\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.fetaldna.it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Articles - FetalDNA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fetaldna.it\/en\/publications\/","og_locale":"en_US","og_type":"article","og_title":"Articles - FetalDNA","og_description":"[vc_row full_width=”stretch_row” softing_row_overlay_type=”custom” softing_bg_attachment=”fixed” softing_lg_bgpos=”center” softing_row_overlayclr=”rgba(242,72,62,0.4)” css=”.vc_custom_1640178087195{padding-top: 100px !important;padding-bottom: 100px !important;background-image: url(https:\/\/www.fetaldna.it\/wp-content\/uploads\/2021\/12\/Sfondo_Altamedica_grigio-1.png?id=13217) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column css=”.vc_custom_1640178140620{padding-top: 100px !important;padding-bottom: 54px !important;}”][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_custom_heading text=”ARTICLES LIST” font_container=”tag:h1|text_align:left” use_theme_fonts=”yes”][\/vc_column][\/vc_row][vc_row softing_row_prepad=”ptb-30″ softing_row_overlay_type=”custom”][vc_column][vc_column_text]Dello Russo C., Cesta A., Longo S., Barone M.A., Cima A., Mesoraca A., Sparacino D., Viola A., Giorlandino C.[\/vc_column_text][vc_custom_heading text=”Validation of Extensive Next-Generation Sequencing...","og_url":"https:\/\/www.fetaldna.it\/en\/publications\/","og_site_name":"FetalDNA","article_modified_time":"2022-02-28T22:59:23+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.fetaldna.it\/en\/publications\/","url":"https:\/\/www.fetaldna.it\/en\/publications\/","name":"Articles - FetalDNA","isPartOf":{"@id":"https:\/\/www.fetaldna.it\/#website"},"datePublished":"2022-02-27T22:26:57+00:00","dateModified":"2022-02-28T22:59:23+00:00","breadcrumb":{"@id":"https:\/\/www.fetaldna.it\/en\/publications\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fetaldna.it\/en\/publications\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.fetaldna.it\/en\/publications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fetaldna.it\/en\/"},{"@type":"ListItem","position":2,"name":"Articles"}]},{"@type":"WebSite","@id":"https:\/\/www.fetaldna.it\/#website","url":"https:\/\/www.fetaldna.it\/","name":"FetalDNA | Il test prenatale su DNA fetale","description":"Il test prenatale di ultima generazione","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fetaldna.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/pages\/13883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/comments?post=13883"}],"version-history":[{"count":8,"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/pages\/13883\/revisions"}],"predecessor-version":[{"id":13895,"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/pages\/13883\/revisions\/13895"}],"wp:attachment":[{"href":"https:\/\/www.fetaldna.it\/en\/wp-json\/wp\/v2\/media?parent=13883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}